Appendix B.
Incremental cost per colonization and infection averted per 10,000 ICU admissions for alternative strategies under assumption that MRSA prevalence is 20%.
Strategy | Total costs (in millions) |
Disease costs (in millions) |
Intervention costs (in millions) |
Cases of colonization averted |
Cases of infection averted |
Incremental cost per colonization averted |
Incremental cost per infection averted |
---|---|---|---|---|---|---|---|
Universal decolonization | $6.57 | $5.73 | $0.84 | 1,752 | 543 | -- | -- |
UCP + universal decolonization | $6.81 | $4.17 | $2.64 | 2,079 | 644 | $719 | $2,329 |
ASC testing plus selective decolonization | $7.68 | $6.97 | $0.71 | 1,513 | 468 | Dominated | Dominated |
UCP + universal CHG | $8.25 | $6.13 | $2.12 | 1,601 | 513 | Dominated | Dominated |
Universal CHG | $8.48 | $8.18 | $0.30 | 1,183 | 377 | Dominated | Dominated |
ASC testing alone | $10.91 | $10.21 | $0.70 | 817 | 261 | Dominated | Dominated |
UCP alone | $12.94 | $11.08 | $1.86 | 596 | 192 | Dominated | Dominated |
Standard precautions | $13.95 | $13.95 | -- | -- | -- | Dominated | Dominated |